123 related articles for article (PubMed ID: 12652958)
21. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
[TBL] [Abstract][Full Text] [Related]
22. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
23. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
24. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Francis GS; Gassler JP
Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
[No Abstract] [Full Text] [Related]
25. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
[TBL] [Abstract][Full Text] [Related]
26. Effect of treatment on survival in an animal model of chronic heart failure.
Bastien N; Lambert C
Am J Cardiol; 1998 Nov; 82(10A):50S-52S. PubMed ID: 9860360
[No Abstract] [Full Text] [Related]
27. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
Nieminen MS; Kupari M
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
29. The safety profile of quinapril: is there a difference among ACE inhibitors?
Canter D; Frank GJ; Knapp LE; McLain RW
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
[TBL] [Abstract][Full Text] [Related]
30. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
31. Overview of quinapril, a new ACE inhibitor.
Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
[TBL] [Abstract][Full Text] [Related]
32. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
Banas JS
Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
[TBL] [Abstract][Full Text] [Related]
33. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
[No Abstract] [Full Text] [Related]
34. Effect of quinapril on blood pressure and heart rate in congestive heart failure.
Townend JN; West JN; Davies MK; Littler WA
Am J Cardiol; 1992 Jun; 69(19):1587-90. PubMed ID: 1598874
[TBL] [Abstract][Full Text] [Related]
35. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
Schön HR; Dorn R; Barthel P; Schömig A
J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
[TBL] [Abstract][Full Text] [Related]
36. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
[TBL] [Abstract][Full Text] [Related]
38. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
Lough M; Cleland J; Langan J; Cowley A; Wade A
BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
[No Abstract] [Full Text] [Related]
39. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Gavazzi A; Marioni R; Campana C; Montemartini C
J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
